SWIFT Certifies Fiorano ISO 20022 Accelerator for Cross-Border Payments and Reporting
1.7.2020 11:00:00 EEST | Business Wire | Press release
Fiorano Software, a leading provider of enterprise integration middleware, API management and banking solutions, today announced confirmation by the Society for Worldwide Interbank Financial Telecommunications (SWIFT) of Fiorano’s support for SWIFT’s Cross-Border Payments and Reporting Plus (CBPR+) message specifications. Fiorano is now one of a select set of worldwide vendors whose solution has cleared certification requirements by SWIFT for CBPR+ readiness.
Fiorano also recently announced the availability of a SWIFT-Confirm pack to confirm payments, corresponding to the November 2020 “universal confirmations” deadline, through SWIFT-approved automated routes including MT 199, API calls and CSV batches with an easy upgrade path to SWIFT gpi and SWIFT CBPR+ / ISO 20022.
“Being able to deliver out-of-the-box support for SWIFT Universal Confirmations and CBPR+ as an overlay service is critical for Banks and Financial Institutions looking to meet immediate SWIFT and broader ISO 20022 requirements without upgrading existing backend systems,” said Biju Suresh Babu, Managing Director – Banking and Financial Services, Fiorano Software. “Fiorano has been steadily adding functionality and features aimed at helping customers and partners deliver ISO 20022 compliance in line with SWIFT and broad global payment scheme support with minimal impact and disruption,” he added.
Built on the proven enterprise-class, secure and scalable Fiorano Hybrid Integration Platform (HIP), coupled with a powerful set of ISO 20022-ready adapters, the Fiorano ISO 20022 Accelerator enables rapid adoption of the ISO 20022 messaging standard through connectors and tools that facilitate code-less implementations for rapid readiness.
About Fiorano : Fiorano Software, a Silicon Valley based Corporation, is a trusted provider of hybrid integration and API technology, enabling interoperability, profitability and new revenue streams, since 1995. Fiorano operates through its worldwide offices and a global network of technology partners and value-added resellers. Global companies including AT&T Wireless, Federal Bank, NASA, Bank of Kigali, Commercial Bank of Africa, Canadia Bank, US Coast Guard and Vodafone have deployed Fiorano to drive innovation through open, standards-based, event-driven, real-time solutions yielding unprecedented productivity.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005364/en/
Contact information
Sumit Kuhite
+1 650 326 1136
mediarelations@fiorano.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 13:00:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 13:00:00 EEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 12:15:00 EEST | Press release
HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612936893/en/ HUI (HUI:VSE) merges traditional and crypto finance: commences continuous trading in Vienna with leading market maker and announces impending token listing on major global exchange Emmanuelle Deba
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 10:35:00 EEST | Press release
India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 10:00:00 EEST | Press release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom